Focus Partners Wealth
DERM icon

Focus Partners Wealth’s Journey Medical DERM Stock Holding History

Focus Partners Wealth’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-18,975
Closed -$89K – 2823
2026
Q1 		$89K Sell
18,975
-735
-4% -$5.71K ﹤0.01% 2527
2025
Q4 		$152K Buy
+19,710
New +$155K ﹤0.01% 2493

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Focus Partners Wealth's DERM Position: Q2 2026 in Review

Focus Partners Wealth sold out of Journey Medical (DERM) in Q2 2026, closing a stake of 18,975 shares — an estimated $89K sold.

Focus Partners Wealth first reported a position in DERM in Q4 2025 and held it in 2 quarters. The position peaked at $152K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Focus Partners Wealth reported no remaining Journey Medical position as of Q2 2026 after selling out during the quarter.
  • Focus Partners Wealth sold 18,975 Journey Medical shares in Q2 2026, an estimated $89K.
  • Focus Partners Wealth first reported a position in Journey Medical in Q4 2025 and held it in 2 quarters.
  • Focus Partners Wealth's Journey Medical position peaked at $152K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Focus Partners Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.